✦ LIBER ✦

Final report of ifosfamide (I), cisplatinum (C) and 4-epirubicin (E) in the treatment of advanced non-small cell lung cancer (NSCLC)

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Phase II trial of high dose epirubicin a

📂 Article 📅 1991 🏛 Elsevier Science 🌐 English ⚖ 126 KB

Phase I study of ifosfamide plus high-do

✍ C. Gridelli; Antonio Rossi; Pasquale Incoronato; Giovanni Salvatore Bruni; Franc 📂 Article 📅 1996 🏛 Springer 🌐 English ⚖ 59 KB

Methotrexate (MTX), mitomycin C (MMC), v

📂 Article 📅 1994 🏛 Elsevier Science 🌐 English ⚖ 175 KB

101 Navelbine (N) ifosfamide (I) cisplat

✍ Gottfried, M.; Yelin, A.; Shapira, A.; Burillon, J.P.; Martinez, A.; Rozenman, Y 📂 Article 📅 1997 🏛 Elsevier Science 🌐 English ⚖ 162 KB

A phase I trial of cisplatin (CDDP), doc

✍ Kunitoh, H; Sawada, M; Watanabe, H; Akiyama, Y; Kusaba, H; Yamamoto, N; Sekine, 📂 Article 📅 2000 🏛 Elsevier Science 🌐 English ⚖ 103 KB

Phase I study of high dose cisplatin, if

📂 Article 📅 1991 🏛 Elsevier Science 🌐 English ⚖ 114 KB